Nitric oxide attenuates cardiac myocyte contraction AJ Brady, JB Warren, PA Poole-Wilson, TJ Williams, SE Harding American Journal of Physiology-Heart and Circulatory Physiology 265 (1 …, 1993 | 614 | 1993 |
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia AJ Brady, PA Poole-Wilson, SE Harding, JB Warren American Journal of Physiology-Heart and Circulatory Physiology 263 (6 …, 1992 | 517 | 1992 |
Expression of inducible nitric oxide in human lung epithelial cells RA Robbins, PJ Barnes, DR Springall, JB Warren, OJ Kwon, LDK Buttery, ... Biochemical and biophysical research communications 203 (1), 209-218, 1994 | 469 | 1994 |
Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation RA Robbins, DR Springall, JB Warren, OJ Kwon, LDK Buttery, AJ Wilson, ... Biochemical and biophysical research communications 198 (3), 835-843, 1994 | 253 | 1994 |
Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light JB Warren The FASEB journal 8 (2), 247-251, 1994 | 166 | 1994 |
Cytokine stimulated endothelin release from endothelial cells SM Kanse, K Takahashi, HC Lam, A Rees, JB Warren, M Porta, ... Life sciences 48 (14), 1379-1384, 1991 | 117 | 1991 |
Effect of adrenergic and vagal blockade on the normal human airway response to exercise JB Warren, SJ Jennings, TJH Clark Clinical Science 66 (1), 79-85, 1984 | 116 | 1984 |
Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant JB Warren, LE Donnelly, S Cullen, BE Robertson, MA Ghatei, SR Bloom, ... European journal of pharmacology 197 (2-3), 131-134, 1991 | 103 | 1991 |
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans JB Warren, JR Cockcroft, SW Larkin, R Kajekar, A Macrae, MA Ghatei, ... Journal of cardiovascular pharmacology 20 (1), 83-87, 1992 | 101 | 1992 |
Pulmonary endothelium-derived relaxing factor is impaired in hypoxia JB Warren, NH Maltby, D MacCormack, PJ Barnes Clinical Science 77 (6), 671-676, 1989 | 90 | 1989 |
Nitric oxide biology: implications for cardiovascular therapeutics JB Warren, F Pons, AJB Brady Cardiovascular research 28 (1), 25-30, 1994 | 88 | 1994 |
Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells SM Kanse, K Takahashi, JB Warren, M Ghatei, SR Bloom European journal of pharmacology 199 (1), 99-101, 1991 | 83 | 1991 |
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo. JB Warren, SW Larkin, M Coughlan, R Kajekar, TJ Williams British journal of pharmacology 106 (2), 331, 1992 | 76 | 1992 |
Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs BE Robertson, JB Warren, PC Nye Experimental Physiology: Translation and Integration 75 (2), 255-257, 1990 | 76 | 1990 |
Opposing roles of cyclic AMP in the vascular control of edema formation JB Warren, AJ Wilson, RK Loi, ML Coughlan The FASEB journal 7 (14), 1394-1400, 1993 | 71 | 1993 |
Effect of enalapril on the skin response to bradykinin in man. RW Fuller, JB Warren, M McCUSKER, CT Dollery British journal of clinical pharmacology 23 (1), 88-90, 1987 | 68 | 1987 |
Precaution, cyclooxygenase inhibition, and cardiovascular risk JM Ritter, I Harding, JB Warren Trends in Pharmacological Sciences 30 (10), 503-508, 2009 | 66 | 2009 |
Caution with use of inhaled nitric oxide JB Warren, T Higenbottam The Lancet 348 (9028), 629-630, 1996 | 66 | 1996 |
A comparison of the bronchodilator and vasopressor effects of exercise levels of adrenaline in man. JB Warren, N Dalton Clinical Science (London, England: 1979) 64 (5), 475-479, 1983 | 66 | 1983 |
Endotoxin‐induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis JB Warren, ML Coughlan, TJ Williams British journal of pharmacology 106 (4), 953-957, 1992 | 65 | 1992 |